1-4 of 4
Linda Richmond
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

BMS-214662 potently induces apoptosis of chronic myeloid leukemia stem and progenitor cells and synergizes with tyrosine kinase inhibitors

Mhairi Copland, Francesca Pellicano, Linda Richmond, Elaine K. Allan, Ashley Hamilton, Francis Y. Lee, Roberto Weinmann, Tessa L. Holyoake
Journal: Blood
Blood (2008) 111 (5): 2843–2853.
https://doi.org/10.1182/blood-2007-09-112573
Published: 2008
Includes: Supplemental data
Journal Articles

BMS-214662 Eliminates CML Stem Cells and Is Active Against Blast Crisis CML and Cells Expressing BCR-ABL Kinase Mutations.

Mhairi Copland, MD, Linda Richmond, BSc, Ashley Hamilton, BSc, Elaine K. Allan, BSc, Junia V. Melo, MD, PhD, Tessa L. Holyoake, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 739.
https://doi.org/10.1182/blood.V108.11.739.739
Published: 2006
Journal Articles

Enhanced Primary CML Stem Cell Elimination by Bryostatin Priming with Imatinib Mesylate In Vitro .

Heather G. Jorgensen, PhD, MRPharmS, Elaine K. Allan, BSc (Hons), Joanne C. Mountford, PhD, Linda Richmond, BSc(Hons), Moira A. Elliott, PhD, MRPharmS, Tessa L. Holyoake, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 1997.
https://doi.org/10.1182/blood.V104.11.1997.1997
Published: 2004
Journal Articles

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

Susan M. Graham, Heather G. Jørgensen, Elaine Allan, Charlie Pearson, Michael J. Alcorn, Linda Richmond, Tessa L. Holyoake
Journal: Blood
Blood (2002) 99 (1): 319–325.
https://doi.org/10.1182/blood.V99.1.319
Published: 2002